GUEST LECTURE IN FULL
J.R.T.C. Roelandt*, MD, FACC,
Chairman Department of Cardiology, Thoraxcentre, Erasmus MC,
Rotterdam, The Netherlands
|

|
Echocardiography is currently the most widely used and cost-effective
diagnostic imaging tool in cardiology. Since it
is often the best or even the only applicable
method, it has largely supplanted other imaging
modalities in a wide variety of health care environments.
Miniaturization and digital techniques recently
resulted in the development of high resolution
battery-powered personal ultrasound imaging devices
with excellent grey-scale and color blood flow
imaging capabilities.
These personal imagers are appropriately
named "ultrasound stethoscopes" since they make
it possible to look into the chest (stethos=chest
and skopein=see) and see the heart and its pathology
during physical examination.
They can be used anytime anywhere just like
a conventional stethoscope.
1 We will discuss the potential of these small
ultrasound imaging devices in different clinical
scenarios and how they may extend the physical
examination and the practice of cardiology.
Two small hand-held ultrasound imagers have recently
been introduced (SonoHeartTM, SonoSite, Inc. Bothell,
WA, USA and OptiGoTM, Agilent Technologies, Andover,
MA, U.S.A.) (fig 1). They are based on miniaturized
digital technology and make use of phased array
transducers providing high-resolution two-dimensional
dynamic grey-scale tissue imaging combined with
color Doppler flow imaging (directional for the
SonoHeartTM).
The upgraded SonoHeart PlusTM device features
second harmonic imaging and has integrated M-mode
and pulsed-wave Doppler capabilities as well as
an electrocardiographic reference lead.
The devices operate on a rechargeable battery
or AC current and have measurement packages including
linear measurement callipers. The internal memory
of the SonoHeartTM allows storage up to 120 images,
which can be downloaded into a PC and there is
a video output, which can be connected to a monitor
or to a VCR for permanent recording.
The OptiGoTM allows images to be documented on
a CompactFlash card. Other companies are also
developing miniaturised ultrasound imaging systems.
The TerasonTM device (Teratech Corp, Burlington,
MA, USA) has the micro-miniaturised ultrasound
system incorporated in the transducer and connects
to a notebook PC (fig 1). The small ultrasound
devices should not be confused with the portable
desktop systems which are full featured systems.

Figure 1
Figure 1. Photographs of the (A) MinivisorTM developed
in 1978.32-34 and currently available hand-held
ultrasound devices (B) OptiGoTM, (C) SonoHeartTM
and (D) TerasonTM.
|
The examination procedure with these devices is the same as with standard echocardiography and all precordial windows can be used for structure and blood flow imaging. Our experience with the SonoHeartTM and OptiGoTM device indicates that morphologic data obtained in standard cardiac views and basic linear measurements of structures and cavities adequately compare with those documented with standard equipment.2

The physical examination remains the cornerstone of the initial evaluation
of a patient with suspected cardiovascular disease.
However, notable shortcomings in examination skills
and more particularly in auscultation have
been documented even after training with innovative
instructional methods.3-6 In addition, over the
years, echo/Doppler studies have brought out the
limitations of the physical examination in many
cardiac conditions, particularly in the early
stages of disease and no quantitative information
is obtained.7 “Visualising the heart” with the
ultrasound stethoscope as part of the physical
examination provides additional information beyond
what we can perceive with palpation and auscultation
and permits rapid confirmation of a cardiac abnormality
(valve disease, shunt (fig 2), cavity dilatation,
hypertrophy, pericardial effusion, wall motion
abnormality) and a specific diagnosis in any clinical
setting can be made (table 1 and fig 3).
Incidental findings are also regularly recognized.8,9
The routine physical cardiac examination can be
extended by imaging and by obtaining limited quantitative
measurements of the inferior vena cava, liver,
spleen and abdominal aorta. The loss of inspiration
narrowing of the inferior vena cava is a reliable
and sensitive marker of elevated central venous
pressure and right heart failure (fig 4).10 The
major strength of a limited echo/Doppler examination
is its specificity that allows exclusion of a
cardiac abnormality with great certainty after
limited training. However, it is crucial to have
sensitive color flow imaging capabilities. Standard
echocardiography involves a comprehensive examination
with complex equipment by an operator with considerable
training and experience. However, the diagnosis

Figure 2
Figure 3
|

|
Figure 3. Apical four chamber view of a 25-years-old-female with systemic lupus erythematosus and shortness of breath. The referral diagnosis was: pericarditis? The patient has regurgitant jets of aortic regurgitant (A) and mitral regurgitation (B), but no pericarditis (OptiGoTM).
|

Figure 4
|

|
Figure 4. Imaging of the inferior vena cava (IVC) through the liver during expiration (A) and inspiration (B). The caliper function allows measurement of the IVC dimension during expiration (2.6 cm) and during inspiration (1.9 cm). A collapse of less than 50% indicates an elevated right-sided filling pressure37 (OptiGoTM).
|
and follow-up of many cardiac conditions requires only a fraction of
the potential of these expensive facilities and a specific clinical
question can often be answered within little time and with little
examination protocols. 9,11-13 The ultrasound stethoscope is very suitable
for such a “focussed” or “goal-oriented” examination.
The resolution of a pericardial effusion after a pericardiocentesis
(fig 5), cardiac dimensions and left ventricular (LV) function both of
which are important parameters in the follow-up of many patients are
rapidly assessed at the bedside (agreement for semi-quantitative LV size
assessment between standard echocardiography and SonoHeartTM in 111
consecutive patients was 99%; kappa value 0.970 and for ejection fraction
93%; kappa value 0.871)1.
Patients with hypertension and LV hypertrophy have an increased risk
of a cardiovascular event and the success or failure of their
antihypertensive treatment can be assessed by wall thickness measurements
(figure 6).9,12,14 “Goal-oriented” echocardiography will undoubtedly
become part of the initial physical examination by primary care physicians
to identify or exclude a cardiac condition who will use telecommunication
technology for consultation in the future.
15 The ultrasound stethoscope can effectively

Figure 5
|

|
Figure 5. Long-axis views of patients with pericardial effusion (PE). (A) A small PE postoperatively and (B) a large PE of a patient with clinical signs of tamponade (SonoHeartTM).
|

Figure 6
|

Figure 6. Measurement of septal thickness in a 49-years-old man with hypertension using the integrated calliper function. Thickness is 1.3 cm (normal < 1.2 cm) (SonoHeartTM).
|
assist in the initial evaluation and rapid diagnosis of potentially life threatening
conditions in the intensive care environment or
in situations where quick-decision making is essential.
In many such situations standard echocardiography
is not rapidly available.
The ultrasound stethoscope carried by the attending
cardiologist provides data inaccessible by clinical
examination and allows immediate diagnosis or
exclusion of emergent tamponade, a dilated heart,
and valvular pathology (e.g. calcific aortic stenosis
in low output state) (fig7 and 8). Pericardiocentesis
can be guided and the effects of acute interventions
(e.g. fluid challenge n hemodynamically compromised
patients, inotropic drugs) monitored through estimation
of cavity dimensions, ejection fraction and wall
dynamics (fig 9). In a recent study by Goodkin
et al16, the potential of a hand-held device to
rapidly obtain important clinical information
during the physical examination in critically
ill patients was demonstrated. However, proper
management of these patients often requires hemodynamic
data which are obtained with standard equipment.
Immediate echocardiographic assessment in the
emergency room has been reported to considerably
shorten the time to diagnosis of penetrating cardiac
injury and to improve the chances of survival.17-20
Right ventricular involvement in acute myocardial
infarction and the mechanical complications of
a myocardial infarction are readily diagnosed
in the coronary care unit.
Echocardiography of the right heart is of
great value in patients with acute pulmonary embolism.21
The demonstration of right ventricular dilatation
and paradoxical septal motion in patients clinically
suspected raises the level of suspicion significantly
while their absence does not exclude pulmonary
embolism. On the other hand, many conditions that
clinically mimic pulmonary embolism are rapidly
identified.22 Regional wall function abnormalities
are reliably detected (90% agreement in 204 segments
of 34 patients), a potential which can be utilized
in chest pain clinics for rapid screening in the
context of acute chest pain and a non-diagnostic
electrocardiogram in chest pain clinics.3 The
ultrasound stethoscope could be used for

Figure 7
|

|
Figure 7. Long-axis view of a 72-years-old man with no history of cardiac disease and progressive dyspnea. His referral diagnosis was: cardiomyopathy? A calcific aortic valve is seen with turbulent flow in the aorta in systole and a regurgitant jet in the outflow tract in diastole. The left ventricular end-diastolic dimension is 60 mm. The patient has degenerative calcific aortic stenosis and regurgitation (OptiGoTM).
|

Figure 8
|

|
Figure 8. Apical four chamber view of a 45-years-old male with dilated cardiomyopathy. (A) A mitral regurgitant jet is visualised (SonoHeartTM). The imaging quality of the hand-held device can be appreciated against that of a standard echocardiographic system (HP, Sonos 5000TM).
|
screening and identifying unexpected cardiac disorders with a low
prevalence in a specific population. However, the sensitivity of these
devices for identifying certain conditions is still to be defined and the
competence and training level of the examiner is an important aspect to
consider. The feasibility of community screening for asymptomatic LV
dysfunction has been demonstrated.23 The ultrasound stethoscope allows
rapid screening for an occult aortic abnominal aneurysm in patient groups
“at risk” (patients with coronary artery disease, hypertension,
elderly) (fig 10).24-26 Physical examination is notably insensitive in
moderately enlarged aneurysmata and obese patients. Aortic diameter
measurements compared well to those obtained with standard equipment
(agreement 97% in 100 consecutive patients; kappa value 0.810) and are
obtained in a few minutes during a routine physical examination.

Figure 9
|

|
Figure 9. Principle of estimating of left ventricular ejection
function in the parasternal long axis view. A calliper function
allows to measure the left ventricular dimensions in end-diastole
(5.26 cm ) and end-systole (2.99 cm) – the fractional shortening
is 45% (SonoHeartTM).
|

Figure 10
|

|
Figure 10. Imaging of the abdominal aorta. (A) Normal abdominal aorta - dimension 2.1 cm (OptiGoTM) and (B) aneurysm of the abdominal aorta (dimension 5.0 cm) (SonoHeartTM).
|

Figure 11
|

Figure 11. Apical four chamber view of a 65-years-old
female with prolapse of the posterior mitral
leaflet and eccentric jet towards the interatrial
septum. The patient was referred for the
evaluation of palpitations and was known
to have a systolic murmur (OptiGoTM).
|
Limited echocardiography allows to screen for left ventricular hypertrophy
(agreement with standard echocardiography in 100
consecutive patients 92%, kappa value 0.730) and
to follow the effect of treatment in office practice.12
Mitral valve prolapse is often suspected in otherwise
asymptomatic individuals. This disorder can be
excluded or confirmed in a limited number of standard
views (figure 11).27 Potentially dangerous conditions
can be identified in preparticipation screening
of athletes. Hypertrophic cardiomyopathy, a dilated
ascending aorta (Marfan) (figure 12) and valvular
abnormalities (bicuspid valve, mitral valve prolapse)
are the most common disorders and are reliably
detected by experienced examiners.24-28 However,
screening for cardiac disorders in young athletes
and asymptomatic individuals involves a high risk
of a false positive diagnosis.
Figure 12
In 1904, W. Rollins described the “Seehear”, a device combining a
fluoroscope with a standard stethoscope extending the clinical perception of
the auscultation with seeing. Clearly, ultrasound offers obvious advantages
over x-rays. We developed and used an ultrasound stethoscope (MinivisorTM,
Organon Teknica) as early as 1978.29-32 and in 1988, a hand-held sector scanner
(ScanMateTM, Damon Corp) was introduced by the Rochester group.30,31 However
limited imaging performance and reimbursement issues did not stir the
enthusiasm of cardiologists who were confronted in those days with the rapidly
expanding capabilities and applications of the high-end ultrasound
systems.
Now, technology allows to construct small personal imaging systems with
excellent structure and blood flow imaging. Expanding our routine physical
examination with a small personal imager will significantly strengthen our
diagnostic capabilities (table 2) On the basis of normal structure and
functional findings in the absence of blood flow turbulence, all of which can
be tested in a limited number of imaging views, a cardiac disorder can be
excluded with a high degree of certainty.
This high negative predictive value is ideal for rapid screening to avoid
referral of normals and for a more cost-effective use of our expensive
diagnostic imaging facilities.
Personal imagers will therefore have an impact not only on the physical
examination but also on

Higher diagnostic specificity and sensitivity
|
Functional assessment
|
Blood flow information
|
Inferior vena cava collapse
|
Quantitative information
|
Abdominal aorta measurement
|
the use of echocardiography and other imaging
modalities by targeted referral. A major application
will become its use in a critical care environment.
Direct diagnosis or exclusion of some life-threatening
conditions will shorten delays in proper management
and therapy and lead to important cost-savings.
These devices are extremely suited for a
limited “focussed” ultrasound examination to follow
the course of a disease or to test the effect
of therapy in the outpatient clinic in office
practice. Obviously, a small ultrasound imager
must be used as an adjunct of the physical examination
and cannot substitute for the high-end ultrasound
systems.
15 Therefore, its use involves some compromises
which will be learned when applications are expanding.
Training of non-echocardiographers may become
an important issue and should focus on criteria
of normalcy and identifying both major and acute
cardiac disorders. In fact, the device should
be used in a way comparable to auscultation; whenever
there is doubt, further echo/Doppler is examination
is indicated. Training programs and continuing
medical education including performance testing
can be organized with modern electronic means.
n the future, advances in communications and software
will allow for diagnostic support from experienced
laboratories or intensive care units. It should
be remembered that the real value of any imaging
technology is intimately dependent on our intellectual
contribution: how, when and what clinical scenario
it will have its optimal clinical impact.

1. Roelandt JRTC. A personal ultrasound imager (ultrasound stethoscopy).
A revolution in the physical cardiac diagnosis! Eur Heart J 2001;in press.
2. Vourvouri EC, Poldermans D, De Sutter J, et al.
Experience with an ultrasound stethoscope.
J Am Soc Echocardiogr, 2001;14:in press.
3. Hu BS, Altiel F, Popp RL.
Effectiveness of limited training in echocardiography for
cardiovascular diagnosis. Circulation 1996;94 (suppl):I 253.
4. Mangione S, Nieman LZ. Cardiac auscultatory skills of internal medicine and family
practice trainees. A comparison of diagnostic proficiency. JAMA 1997;278:717-22.
5. St. Clair EW, Oddone EZ, Waugh RA, et al. Assessing housestaff diagnostic skills
using a cardiology patient simulator. Ann Int Med 1992;117:751-6.
6. Spencer KT, Anderson AS, Bhargava A, et al.
Physician- performed point-of-care echocardiography using a laptop platform
compared with physical examination in the cardiovascular patients.
J Am Coll Cardiol 2001;37:2013- 8. 7. Popp RL. The physical examination of the future:
echocardiography as part of the assessment. ACC Current Rev 1998;7:79-81.
8. Bossone E, Marcovitz P, Bach DS. Occult cardiac abnormalities are
not uncommon in critically ill patients:
echocardiographic evaluation of 467 consecutive patients admitted to
a medical intensive care. J Am Coll Cardiol 1997;29:438A.
9. Kimura BJ, Pezeshki B, Frack SA, DeMaria AN. Feasibility
of “limited” echo imaging:
characterization of incidental findings.
J Am Soc Echocardiogr 1998:11;746- 50.
10. Kircher BJ, Schiller NB, Himelman MB.
Noninvasive estimation of right atrial pressure from the inspiration collapse
of the inferior vena cava.
Am J Cardiol 1990;66:493-6.
11. Black HR, Weltin G, Jaffe CC. The limited echocardiogram:
a modification of standard echocardiography for use in the routine evaluation
of patients with systemic hypertension.
Am J Cardiol 1991;67:1027-30.
12. Sheps SG, Frohlich ED. Limited echocardiography for hypertensive left
ventricular hypertrophy.
Hypertension 1997;29:560-3.
13. Vourvouri EC, Poldermans D, Schinkel AFL, Koroleva L, Sozzi FB, Bax JJ,
Roelandt JRTC. Left ventricular hypertrophy screening using a hand-held
ultrasound device (Eur Heart J 2001, submitted).
14. De Simone G, Devereux RB, Ganau A, et al. Estimation of left ventricular
chamber and stroke volume by limited M-mode echocardiography and
validation by two- dimensional and Doppler echocardiography.
Am J Cardiol 1996;78:801-7.
15. Pezeshki B, Blanchard DG, Kimura BJ. Can a brief,
single-view “screening”
echo detect significant echo
findings?
Implications regarding telemedicine
evaluation.
Circulation
1998;98:I-844.
16. Goodkin GM, Spevack DM, Tunick PA, Kronzon I. How useful is
hand-carried bedside echocardiography in critically ill patients?
J Am Coll Cardiol 2001;37:2019- 22.
17. Rozycki GS, Pchsner G, Schmidt JA, et al.
A prospective study of surgeon-performed ultrasound as the primary adjuvant
modality for injured patient assessment.
J Trauma 1995;39:492-500.
18. Rozycki GS, Pchsner G, Schmidt JA, et al. A prospective study
of surgeon-performed ultrasound as the primary adjuvant modality for
injured patient assessment.
J Trauma 1995;39:492-500.
19. Rozycki GS, Feliciano DV, Schmidt JA, Cushman
JG, Sisley AC,
Ingram W, Ansley JD.
The role of surgeon-
performed ultrasound in patients with possible cardiac
wounds.
Ann Surg
1996;223:737-46.
20. Rugolotto M, Liang DH, Hu BS, Chang CP, Schnittger I.
Bedside point-of-care echocardiography performed with a new generation
hand-carried device: impact on the management of patients hospitalized
for acute cardiac care.
Eur Heart J 2001; 22 (suppl):S 707.
21. JACC/AHA guidelines for the clinical application of echocardiography:
executive summary.
J Am Coll Cardiol 1997;29:862-79.
22. Ribeiro A. The role of echocardiography Doppler in pulmonary embolism.
Echocardiography 1998;15:769- 77. 23. Lahiri A, Galasko GIW, Senior R. Portable echocardiography-
and innovative tool in the assessment of left ventricular dysfunction
in the community.
Eur Heart J 2001; 22 (suppl):S 706.
24. Bruce CJ, Spittell PC, Montgomery SC, et al. Personal ultrasound imager:
abdominal aortic aneurysm screening.
J Am Soc Echocardiogr 2000;13:674-9.
25. Vourvouri EC, Poldermans D, Schinkel AF, Sozzi FB, Bax JJ, van Urk H,
Roelandt JR.
Abdominal aortic aneurysm screening using a hand-held ultrasound device,
A pilot study. Eur J Vasc Endovasc Surg. 2001;22:352-4.
26. Sianos G, Vourvouri E, Nieman K, Ligthart JM, Thuri A, de Feyter PJ,
Serruys PW, Roelandt JR. Aneurysm of the abdominal aorta.
Circulation 2001;104:E10-1.
27. Kimura BJ, Scott R, Willis CL, DeMaria AN. Accuracy and cost-effectiveness
of single-view echocardiographic screening for suspected mitral valve
prolapse.
Am J Med 2000108:331-3.
28. Murry PM Cantwell JD, Heath DL, Shoop J.
The role of limited echocardiography in screening athletes.
Am J Cardiol 1995;76:849-50.
29. Weidenbener EJ. Krauss MD, Waller BF, Taliercio CP.
Incorporation of screening echocardiography in the preparticipation exam.
Clin J Sport Med 1995;5:86-9.
30. Maron BJ, Bodison SA, Wesley YE, Tucker E, Green KJ.
Results of screening a large group of intercollegiate competitive athletes
for cardiovascular disease.
J Am Coll Cardiol 1987;10:1214-21.
31. Ligtvoet CM, Rijsterborgh H, Kappen L, Bom N.
Real time ultrasound imaging with a hand-held scanner.
Part I – technical description. Ultrasound Med Biol 1978;4:91- 2.
32. Roelandt J, Waldimiroff JW, Baars AM. Ultrasounic real time imaging with
a hand-held scanner. II: Initial clinical experience.
Ultrasound Med Biol 1978;4:93-6.
33. Roelandt J, Cate FJ ten, Hugenholtz PG, et al. The ultrasonic stethoscope:
a miniature hand-held device for real time cardiac imaging.
Roelandt J, Cate FJ ten, Hugenholtz PG, Bom N, Ligtvoet CM.
Circulation 1978;58:II-75.
34. Roelandt J, Bom N, Hugenholtz PG.
The ultrasound cardioscope: a hand-held scanner for real-time cardiac imaging.
J Clin Ultrasound 1980;8:221-5.
35. Schwarz KQ, Meltzer RS. Experience rounding with
a hand-held two-dimensional cardiac ultrasound device.
Am J Cardiol 1988;62:157-9.
36. Xie F, Breese MS, Nanna M, Lichtenberg GS, Allen MN, Meltzer R.
Blinded comparison of an “ultrasound stethoscope”
and standard echocardiographic instrument.
Chest 1988;94:270-4.
37. Sorelli VL, Reeves WC. Noninvasive right and left heart catheterization:
taking the echo lab beyond an image- only laboratory.
Echocardiography 2001;18:31-41.


|